CMS Invites Public Comment on Draft Guidance for Medicare Drug Price Negotiation Program

Summary

The Centers for Medicare & Medicaid Services (CMS) is seeking public input on its draft guidance for the Medicare Drug Price Negotiation Program, which aims to set maximum fair prices for prescription drugs in 2028, as mandated by the Inflation Reduction Act of 2022 (IRA). The draft guidance is available on the CMS website at https://www.cms.gov/priorities/medicare-prescription-drug-affordability/medicare-prescription-drug-affordability.